An AI designed drug has begun phase 1 human trials, marking an important step forward for the pharmaceutical industry. Insilico Medicine, a Hong Kong and New York based biotech company, has dosed the first patient with the drug INS018_055.
AI Designed Drug Begins First Human Trials
AI Designed Drug Begins First Human Trials
AI Designed Drug Begins First Human Trials
An AI designed drug has begun phase 1 human trials, marking an important step forward for the pharmaceutical industry. Insilico Medicine, a Hong Kong and New York based biotech company, has dosed the first patient with the drug INS018_055.